000			02056 a2200577 4500
005			20250518040928.0
264		0	_c20200309
008			202003s 0 0 eng d
022			_a1941-837X
024	7		_a10.1080/13696998.2019.1620243 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarras, Theodore K
245	0	0	_aGuidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease. _h[electronic resource]
260			_bJournal of medical economics _cNov 2019
300			_a1126-1133 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aComorbidity
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGuideline Adherence
650	0	4	_aHealth Expenditures _xstatistics & numerical data
650	0	4	_aHealth Resources _xeconomics
650	0	4	_aHealth Services _xeconomics
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aInsurance Claim Review _xstatistics & numerical data
650	0	4	_aMacrolides _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycobacterium Infections, Nontuberculous _xdrug therapy
650	0	4	_aMycobacterium avium Complex
650	0	4	_aMycobacterium avium-intracellulare Infection _xdrug therapy
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aRespiratory Tract Infections
650	0	4	_aSeverity of Illness Index
650	0	4	_aSex Factors
650	0	4	_aUnited States
700	1		_aMirsaeidi, Mehdi
700	1		_aVinnard, Christopher
700	1		_aChan, Edward D
700	1		_aEagle, Gina
700	1		_aZhang, Raymond
700	1		_aWang, Ping
700	1		_aZhang, Quanwu
773	0		_tJournal of medical economics _gvol. 22 _gno. 11 _gp. 1126-1133
856	4	0	_uhttps://doi.org/10.1080/13696998.2019.1620243 _zAvailable from publisher's website
999			_c29695959 _d29695959